TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
TEVA

Teva Pharma Industries Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

36.80$ +0.7% vs. previous close Closing price · As of: Aug 14, 2026

Statements

Income Statement

Teva Pharma Industries Ltd (TEVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 4,142 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TEVA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
5,563 6,492 5,630 5,686 5,610 5,459 5,065 4,701 4,529 4,559 4,295 4,337 4,264 4,467 4,357 3,870 3,978 4,453 3,982 3,910 3,887 4,100 3,661 3,786 3,595 3,883 3,661 3,878 3,850 4,457 3,819 4,164 4,331 4,229 3,891 4,176 4,480 4,711 3,981 4,142 17,314
2,762 3,102 2,811 2,865 2,967 2,917 2,717 2,640 2,508 2,588 2,440 2,443 2,435 2,510 2,294 2,107 2,126 2,405 2,104 2,037 2,093 2,050 1,921 1,992 1,926 2,113 2,079 2,082 1,999 2,041 2,048 2,140 2,183 2,109 2,014 2,074 2,176 2,056 2,011 1,989 8,232
2,801 3,390 2,819 2,821 2,643 2,542 2,348 2,061 2,021 1,971 1,855 1,894 1,829 1,957 2,063 1,763 1,852 2,048 1,878 1,873 1,794 2,050 1,740 1,794 1,669 1,770 1,582 1,796 1,851 2,416 1,771 2,024 2,148 2,120 1,877 2,102 2,304 2,656 1,972 2,153 9,085
663 684 457 486 545 360 317 290 311 295 261 276 240 374 221 225 258 382 254 248 222 244 225 228 175 210 253 275 253 234 242 269 240 271 247 244 256 267 222 250 995
310 311 236 272 330 492 329 316 309 344 292 296 285 319 304 264 279 327 290 242 291 277 296 313 283 288 296 307 268 292 278 283 298 302 297 305 317 367 304 317 1,305
1,913 2,124 1,664 1,718 1,735 1,717 1,417 1,316 1,363 1,436 1,201 1,238 1,120 1,809 1,872 1,590 6,194 1,642 1,444 1,291 1,171 1,972 2,453 2,743 1,250 2,625 1,595 2,450 1,507 1,660 1,989 2,029 2,199 2,149 1,358 1,647 1,422 2,355 1,318 2,004 7,099
765 -137 895 -5,740 378 -13,017 1,525 -14 16 -3,164 134 -644 -81 148 191 173 -4,342 406 434 582 623 78 -713 -949 419 -855 -13 -654 344 756 -218 -5.0 -51 -29 519 455 882 300 652 149 1,983
150 777 207 238 259 191 271 236 229 225 218 206 211 207 224 223 117 398 290 274 241 180 258 211 252 280 260 268 280 260 250 241 272 763 225 203 209 292 201 200 902
615 -914 688 -5,978 119 -13,208 1,254 -250 -213 -3,387 -84 -850 -292 193 -34 -51 -4,323 183 147 319 379 -175 -950 641 165 -1,100 -234 -891 64 508 -471 -244 -321 -247 294 204 648 91 436 -455 720
207 57 54 -22 -494 -1,471 46 -76 -26 -139 9.0 -179 11 119 -59 -104 16 21 62 98 76 -24 2.0 900 107 154 19 16 -12 41 -52 630 69 28 74 -78 214 -390 67 121 12
348 -973 580 -5,970 530 -11,535 1,055 -176 -208 -2,886 -105 -689 -314 109 69 140 -4,349 150 77 207 292 -159 -955 -232 56 -1,221 -220 -872 69 463 -139 -846 -437 -217 214 282 433 480 369 -576 706
1,367 -101 1,375 -5,163 1,414 -12,580 2,032 465 1,118 -2,728 577 -194 332 1,116 590 554 -3,961 1,117 810 898 1,039 231 -369 1,009 739 -586 803 970 627 1,517 55 246 207 1,162 953 657 1,104 632 877 -19 2,594

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?